NaviFUS™ System Neuromodulating Treatment for Patients With Drug Resistant Epilepsy
NCT04999046
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
12
Enrollment
INDUSTRY
Sponsor class
Conditions
Drug Resistant Epilepsy
Seizure
Seizure Disorder
Epilepsy
Interventions
DEVICE:
NaviFUS System
Sponsor
NaviFUS Corporation